20/20 Biolabs, Inc. (AIDX) › Operating Cash Flow20/20 Biolabs, Inc. (AIDX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2024: -$2.60M2025: -$1.92M-$1.92M2024Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$1.92M+26.1%2024-$2.60M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share